Health and Fitness Health and Fitness
Fri, March 15, 2013
Thu, March 14, 2013
Wed, March 13, 2013
Tue, March 12, 2013
Mon, March 11, 2013
Sun, March 10, 2013
Sat, March 9, 2013
Fri, March 8, 2013
Thu, March 7, 2013
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Alchemia Granted Key US Patent
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
[ Thu, Feb 21st 2013 ] - Market Wire
Inorganic Growth of Healthcare
Wed, February 20, 2013

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 18,


//health-fitness.news-articles.net/content/2013/ .. ull-year-2012-financial-results-on-march-18.html
Published in Health and Fitness on Monday, March 4th 2013 at 4:45 GMT by Market Wire   Print publication without navigation


March 04, 2013 07:30 ET

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013

DEERFIELD, IL--(Marketwire - Mar 4, 2013) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) announced today that its fourth quarter and year ended December 31, 2012 financial results will be released on Monday, March 18, 2013. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update. 

The live webcast and a replay may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 11959520. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 11959520. 

About Horizon Pharma
Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit [ www.horizonpharma.com ].



Publication Contributing Sources